Photo by nci from unsplash
Direct oral anticoagulants (DOACs) are the recommended first‐line therapy for ischemic stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the safety and effectiveness of edoxaban for this indication… Click to show full abstract
Direct oral anticoagulants (DOACs) are the recommended first‐line therapy for ischemic stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the safety and effectiveness of edoxaban for this indication requires monitoring over the long term in real‐world settings.
Keywords:
atrial fibrillation;
nonvalvular atrial;
safety effectiveness;
effectiveness edoxaban;
patients nonvalvular
Journal Title: Journal of Arrhythmia
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Arrhythmia
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!